{
   "keywords" : [
      {
         "slug" : "/wiki/covid-19%20pandemic",
         "index" : 1,
         "name" : "COVID-19 pandemic"
      },
      {
         "index" : 2,
         "slug" : "/wiki/cyprus",
         "name" : "Cyprus"
      },
      {
         "name" : "Moderna",
         "index" : 37,
         "slug" : "/wiki/moderna%20covid-19%20vaccine"
      },
      {
         "name" : "Pfizer-BioNTech",
         "index" : 14,
         "slug" : "/wiki/pfizer-biontech%20covid-19%20vaccine"
      },
      {
         "name" : "mRNA",
         "slug" : "/wiki/mrna",
         "index" : 71
      }
   ],
   "images" : {
      "d390dad66e6441a2c5cad2aaa16faa8f2c532087" : "https://aniportalimages.s3.amazonaws.com/media/details/__sized__/Cyprus-vaccination_aug2-thumbnail-154x87-70.jpg"
   },
   "hash" : "65d09a870ac96cd3435de733c10de99b558327bd",
   "keywords_main" : "COVID-19 pandemic",
   "image" : "https://aniportalimages.s3.amazonaws.com/media/details/__sized__/Cyprus-vaccination_aug2-thumbnail-154x87-70.jpg",
   "subtext" : "Nicosia [Cyprus], August 2 (ANI/Xinhua): Cyprus' Health Ministry said it on Monday started a vaccination program for 12- to 15-year-olds.",
   "slug" : "/feed/2021/08/2/cyprus-begins-a-vaccination-programme-for-children-aged-12-to-15-years-old-who-are-eligible-for-the-pfizer-biontech-and",
   "index" : 7,
   "changes" : [
      {
         "text" : "Cyprus begins a vaccination programme for for children age 12 to 15 years old who are eligible for Pfizer-BioNTech and Moderna mRNA vaccines after 20% of new COVID-19 cases related to these age groups. ",
         "date" : "2021-08-2",
         "hash" : "bb03dca1783b889925d9a009282bad2b4a7a5788",
         "slug" : "/feed/2021/08/2/cyprus-begins-a-vaccination-programme-for-for-children-age-12-to-15-years-old-who-are-eligible-for-pfizer-biontech-and-m",
         "timestamp" : 1627938404
      }
   ],
   "sources" : [
      {
         "title" : "Cyprus starts COVID-19 vaccination for 12- to 15-year-olds",
         "day" : "2",
         "hash" : "d390dad66e6441a2c5cad2aaa16faa8f2c532087",
         "year" : "2021",
         "permalink" : "https://www.aninews.in/news/world/europe/cyprus-starts-covid-19-vaccination-for-12-to-15-year-olds20210802182221",
         "name" : "ANI News",
         "month" : 8
      }
   ],
   "related" : [
      {
         "changes" : [
            {
               "text" : "Ghana's Food and Drugs Authority approve the usage of the Moderna and Pfizer-BioNTech COVID-19 vaccines, bringing the number of approved vaccine to five vaccines. ",
               "date" : "2021-07-28",
               "hash" : "d7c46b013f50de12b9d640547f3dad2293d2090d",
               "timestamp" : 1627506419,
               "slug" : "/feed/2021/07/28/ghana-s-food-and-drugs-authority-approve-the-usage-of-the-moderna-and-pfizer-biontech-covid-19-vaccines-bringing-the-nu"
            }
         ],
         "keywords" : [
            "COVID-19 pandemic",
            "Moderna",
            "Pfizer-BioNTech"
         ],
         "hash" : "353cee0594ec742cd230e0c08bdcc858175db28a",
         "slug" : "/feed/2021/07/28/ghana-s-food-and-drugs-authority-approves-the-usage-of-the-moderna-and-pfizer-biontech-covid-19-vaccines-bringing-the-n",
         "index" : 12,
         "text" : "Ghana's Food and Drugs Authority approves the usage of the Moderna and Pfizer-BioNTech COVID-19 vaccines, bringing the number of approved vaccines in the country to five. ",
         "score" : 3,
         "date" : "2021-07-28"
      },
      {
         "changes" : [
            {
               "slug" : "/feed/2021/07/28/the-italian-medicines-agency-aifa-approves-the-usage-of-the-moderna-covid-19-vaccine-for-teenagers-aged-12-to-17-years",
               "timestamp" : 1627506414,
               "hash" : "c765aab512a7b83fd1862bafda949a33ea1cc21d",
               "date" : "2021-07-28",
               "text" : "The Italian Medicines Agency (AIFA) approves the usage of the Moderna COVID-19 vaccine for teenagers aged 12 to 17 years old, making it the second vaccine to used for teenagers in Italy after Pfizer-BioNTech vaccine. "
            }
         ],
         "index" : 40,
         "slug" : "/feed/2021/07/28/the-italian-medicines-agency-approves-the-usage-of-the-moderna-covid-19-vaccine-for-teenagers-between-the-ages-of-12-and",
         "keywords" : [
            "COVID-19 pandemic",
            "Moderna",
            "Pfizer-BioNTech"
         ],
         "hash" : "8d3f8e2c5e9b39451683eed23de65bff93674f88",
         "score" : 3,
         "date" : "2021-07-28",
         "text" : "The Italian Medicines Agency approves the usage of the Moderna COVID-19 vaccine for teenagers between the ages of 12 and 17, making it the second vaccine to be approved for use in teenagers in Italy after the Pfizer-BioNTech vaccine. "
      },
      {
         "hash" : "1658a1dd9eb2f8fed8813a7486274ac99f56bb70",
         "keywords" : [
            "COVID-19 pandemic",
            "Moderna",
            "Pfizer-BioNTech"
         ],
         "slug" : "/feed/2021/06/29/us-white-house-press-secretary-jen-psaki-announces-that-the-biden-administration-will-ship-2-million-doses-of-the-pfiz",
         "index" : 34,
         "changes" : [],
         "text" : "U.S. White House Press Secretary Jen Psaki announces that the Biden administration will ship 2 million doses of the Pfizer vaccine to Peru and 2.5 million doses of the Moderna vaccine to Pakistan. Additionally, the United States will also send vaccine doses to Bangladesh. ",
         "date" : "2021-06-29",
         "score" : 3
      },
      {
         "text" : "Italy suspends the use of the Oxford-AstraZeneca vaccine in people under the age of 60 nationwide following the death of an 18-year-old woman yesterday and reports of other young people who have been hospitalized in critical condition after receiving their first dose of the vaccine. The Moderna and Pfizer vaccines will be used for the vaccination of people under the age of 60, including for people who already received a first dose of the AstraZeneca vaccine. ",
         "date" : "2021-06-11",
         "score" : 3,
         "hash" : "8c6efe9a5c56cb86f71c26f9d9fd4c53a63cbdda",
         "keywords" : [
            "COVID-19 pandemic",
            "Moderna",
            "Pfizer-BioNTech"
         ],
         "slug" : "/feed/2021/06/11/italy-suspends-the-use-of-the-oxford-astrazeneca-vaccine-in-people-under-the-age-of-60-nationwide-following-the-death-of",
         "index" : 28,
         "changes" : [
            {
               "hash" : "b4cc8e712c9cf9994f820ca0908babdd44b8bbf1",
               "slug" : "/feed/2021/06/11/the-use-of-the-oxford-astrazeneca-vaccine-in-italy-is-suspended-nationwide-to-people-under-the-age-of-60-following-the-d",
               "timestamp" : 1623459987,
               "text" : "The use of the Oxford-AstraZeneca vaccine in Italy is suspended nationwide to people under the age of 60 following the death of a 18-year-old woman yesterday and the cases of other young people hospitalized in critical conditions after getting their first dose of the vaccine. Moderna and Pfizer will be used for the vaccination of people under that age, including for those who were already vaccinated with AstraZeneca for the first shot. ",
               "date" : "2021-06-11"
            }
         ]
      },
      {
         "index" : 26,
         "slug" : "/feed/2021/05/8/the-european-commission-signs-a-new-deal-with-pfizer-and-biontech-to-purchase-900-million-doses-of-its-vaccine-with-an-a",
         "keywords" : [
            "COVID-19 pandemic",
            "Pfizer-BioNTech"
         ],
         "hash" : "b6eefabfff878cbdfe4b493345c0716f0994d8f5",
         "changes" : [
            {
               "hash" : "1e6ee8bf1b3d754a6fcaaa8e1c0e157d82d7ab87",
               "slug" : "/feed/2021/05/8/the-european-commission-signs-a-new-deal-with-pfizer-and-biontech-to-buy-900-million-doses-of-its-vaccine-with-additiona",
               "timestamp" : 1620529562,
               "text" : "The European Commission signs a new deal with Pfizer and BioNTech to buy 900 million doses of its vaccine with additional option of other 900 million doses for delivery from 2021 to 2023 which intent to booster shots against the illness and to allow for the vaccination of children and teenagers. ",
               "date" : "2021-05-8"
            }
         ],
         "score" : 2,
         "date" : "2021-05-8",
         "text" : "The European Commission signs a new deal with Pfizer and BioNTech to purchase 900 million doses of its vaccine with an additional option to purchase another 900 million doses for delivery from 2021 to 2023 which they intend to use as booster shots against the illness and to allow for the vaccination of children and teenagers. "
      },
      {
         "date" : "2021-04-14",
         "score" : 3,
         "text" : "White House COVID-19 Response Coordinator Jeffrey Zients says that the Biden administration will accelerate doses of the Pfizer-BioNTech and Moderna vaccines. The move comes after the United States suspended usage of the Johnson & Johnson vaccine. ",
         "changes" : [],
         "slug" : "/feed/2021/04/14/white-house-covid-19-response-coordinator-jeffrey-zients-says-that-the-biden-administration-will-accelerate-doses-of-the",
         "index" : 38,
         "hash" : "a7be71af55c7093e4150fd297f2e6220a9a9c613",
         "keywords" : [
            "COVID-19 pandemic",
            "Moderna",
            "Pfizer-BioNTech"
         ]
      },
      {
         "slug" : "/feed/2021/03/12/the-world-health-organization-grants-emergency-use-approval-for-the-single-dose-johnson-johnson-vaccine-becoming-the",
         "index" : 43,
         "hash" : "8488cff0001af5c0a078b1574c9b0ff82bd99e7c",
         "keywords" : [
            "COVID-19 pandemic",
            "Moderna",
            "Pfizer-BioNTech"
         ],
         "changes" : [
            {
               "slug" : "/feed/2021/03/12/the-world-health-organization-grants-the-emergency-use-approval-for-single-dose-johnson-johnson-vaccine-becoming-the",
               "timestamp" : 1615597557,
               "hash" : "e644c57379bc6d8eca52cbef7829764e393b292a",
               "date" : "2021-03-12",
               "text" : "The World Health Organization grants the emergency use approval for single-dose Johnson & Johnson vaccine, becoming the third vaccine to be approved after Pfizer and Moderna vaccines. "
            }
         ],
         "date" : "2021-03-12",
         "score" : 3,
         "text" : "The World Health Organization grants emergency use approval for the single-dose Johnson & Johnson vaccine, becoming the third vaccine to be approved after the Pfizer and Moderna vaccines. "
      },
      {
         "slug" : "/feed/2021/02/18/lab-studies-suggest-that-the-pfizer-biontech-and-moderna-covid-19-vaccines-are-significantly-less-effective-in-providing",
         "index" : 42,
         "hash" : "aa79763fde6a653a3d2271602d720e84d6b7707d",
         "keywords" : [
            "COVID-19 pandemic",
            "Moderna",
            "Pfizer-BioNTech"
         ],
         "changes" : [
            {
               "date" : "2021-02-18",
               "text" : "Lab studies suggest the Pfizer–BioNTech and Moderna COVID-19 vaccines are significantly less effective in providing antibody protection against the 501.V2 variant of the disease, most prevalent in South Africa. ",
               "timestamp" : 1613696756,
               "slug" : "/feed/2021/02/18/lab-studies-suggest-the-pfizer-biontech-and-moderna-covid-19-vaccines-are-significantly-less-effective-in-providing-anti",
               "hash" : "4f79053f80d810f9bcb1fb288428e5e2b87ed93d"
            },
            {
               "text" : " Lab studies suggest the Pfizer–BioNTech and Moderna COVID-19 vaccines are significantly less effective in protecting against the 501.V2 variant of the disease, most prevalent in South Africa. [https:--www.theguardian.com-world-2021-feb-18-south-african-covid-variant-may-cut-pfizer-vaccine-protection-by-two-thirds (The Guardian)]Variants of SARS-CoV-2",
               "date" : "2021-02-18",
               "hash" : "9e5470d25931fa7a4b0f56b7e412978a27653bc3",
               "timestamp" : 1613667959,
               "slug" : "/feed/2021/02/18/lab-studies-suggest-the-pfizer-biontech-and-moderna-covid-19-vaccines-are-significantly-less-effective-in-protecting-ag"
            }
         ],
         "date" : "2021-02-18",
         "score" : 3,
         "text" : "Lab studies suggest that the Pfizer–BioNTech and Moderna COVID-19 vaccines are significantly less effective in providing antibody protection against the 501.V2 variant of the disease, which is most prevalent in South Africa. "
      },
      {
         "changes" : [
            {
               "hash" : "3cb91228f0df6995eb18a2cf0ef5ab5d86882cbc",
               "slug" : "/feed/2021/02/2/a-peer-reviewed-results-published-in-the-journal-the-lancet-finds-russia-s-sputnik-v-to-be-916-effective-against-sym",
               "timestamp" : 1612328747,
               "text" : "A peer-reviewed results published in the journal \"The Lancet\" finds Russia's Sputnik V to be 91.6% effective against symptomatic COVID-19 infection. It is the third major vaccine candidate to succeed 90% efficacy, along with the Pfizer and Moderna vaccines. ",
               "date" : "2021-02-2"
            },
            {
               "text" : "A peer-reviewed results published in the journal \"The Lancet\" finds the Russian COVID-19 vaccine to be 91.6% effective against symptomatic COVID-19 infection. It is the third major vaccine candidate to succeed 90% efficacy, along with the Pfizer and Moderna vaccines. ",
               "date" : "2021-02-2",
               "hash" : "ba77f0511dcb773b8a2a5aa3668c18296bd703a0",
               "timestamp" : 1612314349,
               "slug" : "/feed/2021/02/2/a-peer-reviewed-results-published-in-the-journal-the-lancet-finds-the-russian-covid-19-vaccine-to-be-916-effective-a"
            }
         ],
         "slug" : "/feed/2021/02/2/a-peer-reviewed-result-published-in-the-journal-the-lancet-finds-russia-s-sputnik-v-vaccine-to-be-916-effective-agai",
         "index" : 56,
         "keywords" : [
            "COVID-19 pandemic",
            "Moderna",
            "Pfizer-BioNTech"
         ],
         "hash" : "69e421297021ecbdef10ac8e3b707e3c372cc30b",
         "score" : 3,
         "date" : "2021-02-2",
         "text" : "A peer-reviewed result published in the journal \"The Lancet\" finds Russia's Sputnik V vaccine to be 91.6% effective against symptomatic COVID-19 infection. It is the third major vaccine candidate to exceed 90% efficacy, along with the Pfizer and Moderna vaccines. "
      },
      {
         "date" : "2020-03-27",
         "score" : 2,
         "text" : "Cyprus' government is set to release 50 prisoners in order to contain the spread of the virus in the island. ",
         "changes" : [],
         "slug" : "/feed/2020/03/27/cyprus-government-is-set-to-release-50-prisoners-in-order-to-contain-the-spread-of-the-virus-in-the-island",
         "index" : 38,
         "hash" : "a83fe1e79aeeb55d7ee199ba43a27919b5e24d59",
         "keywords" : [
            "COVID-19 pandemic",
            "Cyprus"
         ]
      }
   ],
   "text" : "Cyprus begins a vaccination programme for children aged 12 to 15 years old who are eligible for the Pfizer-BioNTech and Moderna mRNA vaccines after 20% of new COVID-19 cases were related to these age groups. ",
   "keywords_list" : [
      "COVID-19 pandemic",
      "Cyprus",
      "Moderna",
      "Pfizer-BioNTech",
      "mRNA"
   ],
   "date" : "2021-08-2"
}